Public Employees Retirement System of Ohio Acquires Shares of 214,400 Qiagen (NYSE:QGEN)

Public Employees Retirement System of Ohio bought a new position in Qiagen (NYSE:QGEN) during the third quarter, HoldingsChannel.com reports. The fund bought 214,400 shares of the company’s stock, valued at approximately $9,717,000.

Several other hedge funds have also recently made changes to their positions in QGEN. GAMMA Investing LLC raised its stake in shares of Qiagen by 806.5% in the third quarter. GAMMA Investing LLC now owns 562 shares of the company’s stock valued at $26,000 after acquiring an additional 500 shares during the period. Toronto Dominion Bank bought a new position in Qiagen during the 2nd quarter valued at about $27,000. Massmutual Trust Co. FSB ADV raised its position in Qiagen by 39.8% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 853 shares of the company’s stock worth $39,000 after purchasing an additional 243 shares during the period. CWM LLC lifted its stake in Qiagen by 12.0% in the second quarter. CWM LLC now owns 2,505 shares of the company’s stock worth $103,000 after purchasing an additional 269 shares during the last quarter. Finally, Headlands Technologies LLC boosted its position in shares of Qiagen by 396.6% during the second quarter. Headlands Technologies LLC now owns 2,741 shares of the company’s stock valued at $113,000 after buying an additional 2,189 shares during the period. 70.00% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Hsbc Global Res upgraded Qiagen to a “hold” rating in a report on Thursday, October 17th. Jefferies Financial Group reiterated a “buy” rating and set a $54.00 target price (up from $42.00) on shares of Qiagen in a research report on Tuesday. Finally, HSBC cut shares of Qiagen from a “buy” rating to a “hold” rating and set a $49.00 price target on the stock. in a report on Thursday, October 17th. Four equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $51.15.

Qiagen Stock Performance

QGEN stock opened at $46.16 on Thursday. Qiagen has a 1-year low of $39.03 and a 1-year high of $47.44. The business has a 50-day moving average price of $43.13 and a 200 day moving average price of $43.68. The company has a market capitalization of $10.53 billion, a P/E ratio of 118.36, a PEG ratio of 3.37 and a beta of 0.35. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.17 and a quick ratio of 1.89.

Qiagen Company Profile

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories.